top of page

PODCAST #001 Dr. Keith Heinzerling interview: psilocybin clinical trials

We talk with Dr. Keith Heinzerling from the Treatment and Research In Psychedelics (TRIP) program at the Pacific Neuroscience Institute about his experience running a psychedelic clinical trial.



Show highlights:

  • psychedelics for creativity

  • what it's like sitting with a patient that's on a psychedelic trip

  • why TRIP chose psilocybin (active ingredient in magic mushrooms) for their clinical trial

  • surprises as he watches patients experience psychedelics

  • viability of "remote trip monitoring" for psychedelics

  • what Dr. Heinzerling would do if he was the "U.S. drug czar"

Dr. Keith Heinzerling

He is a physician board certified in Internal Medicine and Addiction Medicine. He is the Director of the Treatment & Research in Psychedelics (TRIP) Program at the Pacific Neuroscience Institute in Santa Monica. He is a graduate of the psychedelic therapist training program at the Center for Psychedelic Therapies and Research at CIIS in San Francisco.

Find Dr. Heinzerling at

Recent Posts

See All

How we onboarded devs at Psoirée

Developer Onboarding Guide: Onboarding and unblocking new developers RC and EH — 1/25/24 Table of contents Goals Overview Agenda Assets Tech Stack Version management First steps Conclusion and 90-day


bottom of page